Cannabis Bioscience International Holdings, Inc. (CBIH) stock: key figures, P/E, revenue and dividend

Industrials · United States

Price
0.00 USD
Market cap
2.33 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Cannabis Bioscience International Holdings, Inc. financials

Fiscal year2025
Revenue303,022.00 USD
Gross profit262,916.00 USD
Operating income-421,365.00 USD
EBIT-412,558.00 USD
Net income-548,820.00 USD
Diluted EPS – continuing operations-0.00 USD

Full history since 2022, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Cannabis Bioscience International Holdings, Inc.

Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for industry workers; general education seminars; and on-site training, as well as consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. It is also involved in clinical trials and medical research services through its Alpha Research Institute; and sale of CBD products. The company was founded in 2003 and is headquartered in Houston, Texas.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.